Natixis’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$16 | – | 961 |
|
|
2022
Q4 | $16 | Buy |
+1
| New | +$16 | ﹤0.01% | 1003 |
|
|
2022
Q1 | – | Sell |
-579,961
| Closed | -$13.5M | – | 1145 |
|
|
2021
Q4 | $13.5M | Buy |
579,961
+409,300
| +240% | +$9.55M | 0.05% | 317 |
|
|
2021
Q3 | $2.84M | Buy |
170,661
+158,896
| +1,351% | +$2.64M | 0.01% | 662 |
|
|
2021
Q2 | $287K | Buy |
+11,765
| New | +$287K | ﹤0.01% | 789 |
|
|
2021
Q1 | – | Sell |
-170,240
| Closed | -$9.1M | – | 1052 |
|
|
2020
Q4 | $9.1M | Buy |
+170,240
| New | +$9.1M | 0.03% | 415 |
|
|
2018
Q3 | – | Sell |
-22,565
| Closed | -$345K | – | 770 |
|
|
2018
Q2 | $345K | Buy |
+22,565
| New | +$345K | ﹤0.01% | 742 |
|
|
2018
Q1 | – | Sell |
-12,489
| Closed | -$376K | – | 881 |
|
|
2017
Q4 | $376K | Sell |
12,489
-21,113
| -63% | -$636K | ﹤0.01% | 642 |
|
|
2017
Q3 | $1.27M | Buy |
+33,602
| New | +$1.27M | 0.01% | 482 |
|